BCL2L2 and glioblastoma: According to previous reports, miR-29b suppresses angiogenesis, invasion, and metastasis by inhibiting MMP-2 expression in hepatocellular carcinoma [19]; however, to our knowledge, no study has examined the relationship between miR-29 and BCL2L2 expression and their effect on GBM cell phenotype.